Patents by Inventor Norbert Beuscher

Norbert Beuscher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alkoxylated phenyl and coumarin derivatives useful in the treatment of viral infections
    Patent number: 5489585
    Abstract: Alkoxylated phenyl and coumarin derivatives useful in the treatment of viral infections are disclosed. The compounds are particularly useful in the treatment of picornaviruses, and more particularly in the treatment of rhinoviruses.
    Type: Grant
    Filed: November 9, 1992
    Date of Patent: February 6, 1996
    Assignee: Schaper & Bruemmer GmbH & Co., KG
    Inventors: Norbert Beuscher, Helmut Ritter, Cornelia Bodinet
  • Pharmaceutically active composition extracted from tanacetum parthenium, process for its extraction, and pharmaceutical composition containing same
    Patent number: 5466451
    Abstract: Extraction of pharmaceutically active compositions from a mixture of numerous ingredients, in particular from comminuted plants, such as Tanacetum parthenium, succeeds with a high yield and a surprisingly improved stability of the active substances when the extraction is carried out with a gas, preferably CO.sub.2, in the supercritical state.
    Type: Grant
    Filed: January 29, 1993
    Date of Patent: November 14, 1995
    Assignee: Schaper & Bruemmer GmbH & Co., KG
    Inventors: Norbert Beuscher, Ingo Willigmann
  • Glycoprotein from Avena sativa, process for its preparation, and pharmaceutical compositions containing same
    Patent number: 5151498
    Abstract: A glycoprotein with a molecular weight of 38 kD, isolated from the grain of Avena sativa, exhibits surprising pharmacological properties, including immunomodulating activity. The glycoprotein can be used to treat viral and bacterial infections, and can also be used to counter susceptibility to infection arising from a genetic or temporary immunodeficiency. A process for isolating the glycoprotein from Avena sativa is disclosed.
    Type: Grant
    Filed: April 30, 1990
    Date of Patent: September 29, 1992
    Assignee: Schaper & Bruemmer GmbH & Co. KG
    Inventors: Norbert Beuscher, Karl-Heinz Scheit